CG Pharmaceuticals, Inc
1 clinical trials · Sponsor
◉ Watch CG Pharmaceuticals, Inc
| Record | Firm | Date |
|---|---|---|
| A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma (NCT05249101) | CG Pharmaceuticals, Inc | 2022-08-15 |
Track CG Pharmaceuticals, Inc automatically
Every clearance here is in the API, with alerts when new ones post.